2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$7.53-$4.73 (-38.61%)
Price as of Oct 22, 2026 7:58 PM EDT- $657.5MMarket Cap
- -22.31%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$7.53-$4.73 (-38.61%)
AVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.26 | ||
Change | -$0.10 (-0.81%) | ||
Open | $12.41 | ||
High | $13.18 | ||
Low | $12.22 | ||
Previous Close | $12.36 | ||
Volume | 930,224 | ||
30-Day Average Volume | 1,101,482 | ||
1-Week Change | 3.55% | ||
1-Month Change | -24.18% | ||
1-Year Change | -22.31% | ||
3-Year Change | -58.37% | ||
5-Year Change | -99.81% | ||
Fundamentals | |||
Shares Outstanding | 53.6M | ||
Total Assets | $490.8M | ||
Market Cap | $657.5M | ||
Enterprise Value | $572.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$36.4M | ||
Free Cash Flow | -$20.0M | ||
EBIT | -$36.3M | ||
EBITDA | -$36.3M | ||
Net Working Capital | $386.8M | ||
EPS | -$0.83 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -15 | ||
PEG | -1 | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 240 | ||
Last Split Date | 12/29/2023 | ||
Earnings & Revenue